Mindcure operated three main divisions: iSTRYM, Drug Development, and Female Hypoactive Sexual Desire Disorder (fHSDD) Research.

Mindcure was transitioning from early-stage biotech into a commercial-ready organization. The marketing function needed to shift from brand storytelling to data-driven growth that could support multiple divisions with diverse audiences and regulatory constraints.

• Established data governance policies and standardized reporting.
• Built a predictive model to guide monthly content distribution.
• Deployed Pardot to drive qualified leads for iSTRYM.
• Integrated Salesforce with a global scoring system.

Transitioned marketing into a data-driven decision-making hub, accelerated early adoption interest in iSTRYM, and created a scalable framework to support future growth in Drug Development and fHSDD research initiatives.